How do I scale up my product for commercial launch?

Quotient is your answer.

Commercial manufacturing

Quotient Sciences is a global player in commercial manufacturing of small molecule products for niche therapies including oncology and orphan drugs. Our commercial manufacturing facility located in Philadelphia is designed to handle your high-potency compounds.

Our commercial batch size capabilities include:

  • Up to 500 kg for solid oral dosage forms
  • Up to 350 L for liquid formats using an automated filling line

In addition to manufacturing products for NDA, ANDA, MAA and JNDA registration, the Quotient team can support 505(b)(2) and CBE-30 filings.

Process validation and registration batches


Whether you are preparing for NDA, MAA or Japanese NDA, Quotient has the expertise and regulatory approval to manufacture your validation and registration batches for the U.S., U.K., Europe and Japan.


Phase III and commercial drug product supply

Quotient can support all aspects of your drug product supply for Phase III clinical studies and commercial supply.

  • Manufacture of all oral drug product dosage forms in our FDA-, EU- and PDA-approved facilities
  • Packaging including bottles, blisters, tubs or tubes

Dosage forms

Quotient has vast experience across an array of dosage forms that we manufacture for registration and commercial supply, including:

  • Solid oral dosage forms
  • Oral solutions and suspensions



High-potency API handling

Using our experience across the industry pipeline, Quotient has responded to the challenges associated with the manufacturing of today’s high-potency drug products by ensuring our facilities are capable of handling compounds with a maximum performance-based level of exposure classification.

When you need commercial manufacturing for a simple or complex drug product, Quotient is your answer.

Related Links

Learn more about Commercial Manufacturing

Ready to get started?

Contact us

Ask us a question